The impact of uterine-preserving fibroid therapies on pregnancy success in young women undergoing ART
نویسندگان
doi
10.48309/jmpcr.2026.566723.1946چکیده
Uterine fibroids are common benign tumors affecting reproductive outcomes, particularly among women undergoing assisted reproductive technology (ART). Myomatous nodules may impair implantation, alter endometrial blood flow, and reduce ART success. The study aimed to compare pregnancy rates following ART in women with uterine fibroids after three different organ ‑ preserving treatment approaches: medical therapy, uterine artery embolization (UAE), and myomectomy. A total of 106 women aged 23 – 35 years with uterine fibroids and infertility were included. Patients were divided into three groups: Group 1 (n=35) received medical therapy; Group 2 (n=32) underwent UAE; Group 3 (n=39) underwent myomectomy after medical pretreatment. Clinical, laboratory, and ultrasound evaluations were performed. Pregnancy rates after embryo transfer were compared. Statistical analysis included Student’s t ‑ test and descriptive statistics; p<0.05 was considered significant. Pregnancy rates after ART differed significantly between treatment groups: 22.8% after medical therapy, 12.5% after UAE, and 30.7% after myomectomy. Medical therapy (ulipristal acetate (UPA) or GnRH analogues) resulted in a 35–50% reduction in fibroid size and increased resistance index (RI) on Doppler. UAE was associated with decreased endometrial thickness in 34.4% and node necrosis in 18.7% of patients. Myomectomy demonstrated the most favorable ART outcomes with reduced blood loss and shorter operative time after UPA pretreatment. Myomectomy remains the most effective approach to optimizing ART outcomes for women with intramural and subserosal fibroids. UAE may negatively affect endometrial receptivity, while medical therapy is effective primarily for small fibroids. Individualized treatment selection is essential.